BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,859,000 | +28.5% | 144,596 | +23.9% | 0.02% | +25.0% |
| Q2 2022 | $17,006,000 | +22.1% | 116,708 | -0.6% | 0.02% | +45.5% |
| Q1 2022 | $13,927,000 | -7.6% | 117,458 | +7.4% | 0.01% | +10.0% |
| Q4 2021 | $15,075,000 | -2.4% | 109,389 | -1.6% | 0.01% | -16.7% |
| Q3 2021 | $15,440,000 | +47.1% | 111,148 | +2.8% | 0.01% | +50.0% |
| Q2 2021 | $10,493,000 | +45.7% | 108,081 | +2.6% | 0.01% | +60.0% |
| Q1 2021 | $7,200,000 | -24.1% | 105,334 | -4.8% | 0.01% | -28.6% |
| Q4 2020 | $9,488,000 | +34.0% | 110,702 | +1.7% | 0.01% | +16.7% |
| Q3 2020 | $7,079,000 | +1.0% | 108,892 | +13.6% | 0.01% | -14.3% |
| Q2 2020 | $7,009,000 | +132.2% | 95,868 | +8.0% | 0.01% | +75.0% |
| Q1 2020 | $3,019,000 | -60.4% | 88,728 | -36.6% | 0.00% | -42.9% |
| Q4 2019 | $7,621,000 | +186.6% | 139,993 | +119.7% | 0.01% | +133.3% |
| Q3 2019 | $2,659,000 | +108.4% | 63,728 | +118.8% | 0.00% | +50.0% |
| Q2 2019 | $1,276,000 | +10.6% | 29,131 | +29.9% | 0.00% | +100.0% |
| Q1 2019 | $1,154,000 | +77.3% | 22,425 | +27.4% | 0.00% | 0.0% |
| Q4 2018 | $651,000 | -6.3% | 17,600 | -4.9% | 0.00% | 0.0% |
| Q3 2018 | $695,000 | -12.0% | 18,500 | -7.5% | 0.00% | 0.0% |
| Q2 2018 | $790,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |